Aktionärsstruktur der AstraZeneca PLC
Portrait der AstraZeneca Aktie
Das Unternehmen AstraZeneca PLC aus Großbritannien ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Biotechnologie & Pharmazeutika, Pharma tätig.
ASTRAZENECA PHARMA INDIA LTD ist ein Tochterunternehmen von AstraZeneca.
Das Unternehmen AstraZeneca PLC ist in mehr als 74 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares STOXX Europe 600 Health Care UCITS ETF (DE) gewichtet AstraZeneca mit 9,81% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle AstraZeneca Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen AstraZeneca PLC am höchsten gewichtet ist Insgesamt in 74 ETFs enthalten
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
718 News & Informationen zur AstraZeneca Aktie
5 Top Stock Gainers for Monday: AstraZeneca, Astronics, Teradata
AstraZeneca, Brooks Automation, Teradata, Atea Pharmaceuticals and Astronics are five top stock gainers for Monday.
Why AstraZeneca Shares Are Trading Higher Today
AstraZeneca PLC (NASDAQ:AZN) is trading higher Monday after the company announced its Enhertu data that was presented at the European Society…
AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment
AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.
AstraZeneca Breast Cancer Drug Found to Reduce Risk of Dying
The drug maker said Enhertu significantly reduced the risk of death or disease progression in women with advanced disease in a large clinical trial, the latest sign that its push into oncology is starting to pay off.
Premarket Movers Monday – Pfizer, Netflix, Li Auto, AstraZeneca
Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.
Futures Pointing To Sharply Lower Open On Wall Street
The major U.S. index futures are currently pointing to a sharply lower open on Monday, with stocks likely to see further downside following the drop seen last week.
Tesla, Walt Disney Fall Premarket; AstraZeneca Climbs By Investing.com
Tesla, Walt Disney Fall Premarket; AstraZeneca Climbs
Futures Slide, Europe Tumbles As Evergrande Contagion Shockwave Goes Global
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
AstraZeneca : Ground-breaking Phase III head-to-head DESTINY-Breast03 results featured at ESMO Presidential Symposium support Enhertu as the potential new standard of care in previously treated patien
Ground-breaking Phase III head-to-head DESTINY-Breast03 results featured at ESMO Presidential Symposium support Enhertu as the potential new standard of care in previously treated patients
… | September 20, 2021
HUTCHMED China : — Following surufatinib launch in China in January 2021; NDA acceptance by the U.S. FDA for review in June 2021; and MAA validation by the EMA in July 2021 all for advanced neuroendoc
– Following surufatinib launch in China in January 2021; NDA acceptance by the U.S. FDA for review in June 2021; and MAA validation by the EMA in July 2021 all for advanced… | September 20, 2021
AZN : Imfinzi Plus Chemotherapy Triples Patient Survival At 3-yrs In ES-Small Cell Lung Cancer
(RTTNews) – AstraZeneca Plc.'s (AZN, AZN.L) Imfinzi or durvalumab in combination with a choice of chemotherapies, etoposide plus either carboplati…
AstraZeneca : Enhertu Shows Robust And Durable Tumor Response Of 54.9% In Patients With Lung Cancer
(RTTNews) – AstraZeneca Plc. (AZN, AZN.L) and Daiichi Sankyo's HER2-directed antibody drug conjugate, Enhertu, demonstrated robust and durable tum…
AstraZeneca : Enhertu demonstrated robust and durable tumour response of 54.9% in patients with HER2-mutant metastatic non-small cell lung cancer
First HER2-directed therapy to show a strong tumour response in this population
Data from HER2-mutant cohort of pivotal DESTINY-Lung01 Phase II trial presented at… | September 18, 2021
Mid-Afternoon Market Update: Nasdaq Down 1%; Protagonist Therapeutics Shares Plummet
Toward the end of trading Friday, the Dow traded down 0.47% to 4,587.22 while the NASDAQ fell 1.05% to 15,023.11. The S&P also fell, dropping 0.85% to …
Vax exports may resume by year-end: Poonawalla
In an interview, Poonawalla said India is nearing a level where sufficient stocks to sustain the nationwide vaccination drive is available. SII is also significantly ramping up its capacities, he said.
Worldwide Short Bowel Syndrome Industry to 2026 – Development of Short Bowel Syndrome Drugs is at a Nascent Stage Presents Opportunities
/PRNewswire/ — The “Short Bowel Syndrome Market Research Report by Drug Class (GLP-2, Glutamine, and Growth Hormone), by Region (Americas, Asia-Pacific, and…
Mid-Day Market Update: Crude Oil Falls Over 1%; Helbiz Shares Spike Higher
Midway through trading Friday, the Dow traded down 0.51% to 34,572.50 while the NASDAQ fell 0.78% to 15,062.99. The S&P also fell, dropping 0.72% to …
AstraZeneca : Enhertu demonstrated clinically meaningful and durable response in patients with HER2-positive advanced gastric cancer in DESTINY-Gastric02 Phase II trial
PUBLISHED17 September 2021
17 September 2021 17:05 BST
First… | September 17, 2021
Mid-Morning Market Update: Markets Down; US Consumer Sentiment Edges Higher
Following the market opening Friday, the Dow traded down 0.37% to 34,622.25 while the NASDAQ fell 0.58% to 15,094.19. The S&P also fell, dropping 0.55% …
Scientists Rapidly Advancing Cancer Vaccine Prospects Using Same Technology as Covid-19 Shots
/PRNewswire/ — USA News Group – Using the same technology as their Covid-19 shot, scientists behind the University of Oxford and AstraZeneca PLC (NASDAQ:AZN)…
EU fails to confirm if women, young adults at higher clot risk from AstraZeneca shot By Reuters
EU fails to confirm if women, young adults at higher clot risk from AstraZeneca shot
Nine things to know about investing in Canadian depositary receipts (CDRs)
FP Explains: The new kid on the investing block are Canadian Depositary Receipts. What they are, how to trade them and how they are taxed
BlackRock Variable Series Funds, Inc. Buys Sea, Etsy Inc, Danaher Corp, Sells Boston Scientific Corp, Humana Inc, Abbott Laboratories
GuruFocus Article or News written by insider and the topic is about:
Supply fears lead EU vaccine industry to seek home comforts By Reuters
Supply fears lead EU vaccine industry to seek home comforts
Evening Update: Pandemic dominates federal campaign after Jason Kenney’s reversal in Alberta
Also: Top Chinese general collaborated with fired scientist at Canada’s top infectious-disease lab
Global Gynecology Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021
/PRNewswire/ — Gain comprehensive access to over 400 gynecology deal records from this report “Global Gynecology Partnering 2010-2021: Deal Trends, Players…
China's biotech sector comes of age with big licensing deals, global ambitions
HONG KONG — If investors in China’s biotech industry needed one more sign that the sector is coming of age, then a major licensing deal RemeGen Co Ltd struck…
Analysis-China's biotech sector comes of age with big licensing deals, global ambitions By Reuters
Analysis-China's biotech sector comes of age with big licensing deals, global ambitions
Albireo gibt Verfügbarkeit von Bylvay® (Odevixibat) in Deutschland ab sofort bekannt
– In deutscher Preisliste und allen Apotheken-Softwareprogrammen aufgeführt – – Bylvay ist in den USA, der EU und im Vereinigten Königreich als erste…
Albireo Announces Bylvay® (odevixibat) Now Available In Germany
– Listed on the German national price list and all pharmacy software programs –
– Bylvay is approved in U.S., EU and UK as first drug treatment for
SA’s HIV epidemic raises risk of more Covid-19 variants
“A study of an HIV positive 36-year-old woman showed that Covid-19 stayed in her body for 216 days and mutated rapidly,” reports Bloomberg.
India considers resuming vaccine exports soon, focus on Africa, says source By Reuters
India considers resuming vaccine exports soon, focus on Africa, says source
South Africa risks becoming one of the mutation factories of the world – medical expert
Hundreds of thousands of people may be infected annually by animals carrying coronaviruses related to the one that causes Covid-19 in China and Southeast Asia,…
The U.K.’s Bizarre $1.7 Billion Vaccine Rug-Pull
(Bloomberg Opinion) — Back in February, biotech firm Valneva SE’s proposed Covid-19 vaccine was touted by Boris Johnson’s government as a key plank of its ambitious, whatever-it-takes race to immunize the Brits.
The U.K.
Worldwide Anti-Tumor Drugs Industry To 2026 – Growing Awareness Regarding Early Diagnosis And Treatment For Cancer Is Driving The Market
DUBLIN, Sept. 13, 2021 The “Anti-Tumor Drugs Market Research Report by Indications, by Drug Class, by End User, by Route of Administration, by Distribution
Top Research Reports for Eli Lilly, Exxon Mobil & Lowe's
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Exxon Mobil Corporation (XOM), and Lowe's Companies, Inc. (LOW).
Top Research Reports for Eli Lilly, Exxon Mobil & Lowe's
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Exxon Mobil Corporation (XOM), and Low…